Advertisement
In brief| Volume 38, ISSUE 8, P1638-1640, August 2013

Glucosamine and Chondroitin Sulfate Treatment of Hand Osteoarthritis

      Osteoarthritis of the hand is a common degenerative musculoskeletal condition affecting the health-related quality of life of many adults. Despite the high prevalence of symptomatic hand osteoarthritis, the therapeutic options are limited, and the mainstay of pharmacological treatment includes short-term use of oral analgesic and anti-inflammatory medications.
      • Miller K.L.
      • Clegg D.O.
      Glucosamine and Chondroitin Sulfate.
      However, the well-recognized systemic toxicities with these medications limit their use.
      • Clegg D.O.
      • Reda D.J.
      • Harris C.L.
      • et al.
      Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.
      Recent public interest in alternative treatments for osteoarthritis has resulted from the limitations of conventional medications and the desire to decelerate the degenerative process.
      • Wandel S.
      • Juni P.
      • Tendal B.
      • et al.
      Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis.
      Glucosamine and chondroitin sulfate (CS) are among the most popular nonprescription nutriceutical products in the United States and are widely promoted by manufacturers to have remarkable chondroprotective benefits. This article aims to review the best available evidence to facilitate an evidence-based discussion with patients regarding the efficacy and safety of these products in patients with osteoarthritis of the hand.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Hand Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Miller K.L.
        • Clegg D.O.
        Glucosamine and Chondroitin Sulfate.
        Rheum Dis Clin North Am. 2011; 37: 103-118
        • Clegg D.O.
        • Reda D.J.
        • Harris C.L.
        • et al.
        Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.
        N Engl J Med. 2006; 354: 795-808
        • Wandel S.
        • Juni P.
        • Tendal B.
        • et al.
        Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis.
        BMJ. 2010; (341c4675)
        • Brief A.A.
        • Maurer S.G.
        • DiCesare P.E.
        Use of glucosamine and chondroitin sulfate in the management of osteoarthritis.
        J Am Acad Orthop Surg. 2001; 9: 71-78
        • Ronca F.
        • Palmieri L.
        • Panicucci P.
        • Ronca G.
        Anti-inflammatory activity of chondroitin sulfate.
        Osteoarthritis Cartilage. 1998; 6: 14-21
        • Sherman A.L.
        • Ojeda-Correal G.
        • Mena J.
        Use of glucosamine and chondroitin in persons with osteoarthritis.
        PM R. 2012; 4: S110-S116
        • Vangsness C.T.
        • Spiker W.
        • Erickson J.
        A review of evidence-based medicine for glucosamine and chondroitin sulfate use in knee osteoarthritis.
        Arthroscopy. 2009; 25: 86-94
        • Russell A.S.
        • Aghazedeh-Habashi A.
        • Jamali F.
        Active ingredient consistency of commercially available glucosamine sulfate products.
        J Rhematol. 2002; 29: 2407-2409
        • Richy F.
        • Bruyere O.
        • Ethgen O.
        • Cucherat M.
        • Henrotin Y.
        • Reginster J.Y.
        Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis.
        Arch Intern Med. 2003; 163: 1514-1522
        • Towheed T.E.
        • Maxwell L.
        • Anastassiades T.P.
        • et al.
        Glucosamine therapy for treating osteoarthritis.
        Cochrane Database Syst Rev. 2005; 2 (CD002946)
        • Sawitzke A.D.
        • Shi H.
        • Finco M.F.
        • et al.
        The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis.
        Arthritis Rheum. 2008; 58: 3183-3191
        • McAlindon T.E.
        • LaValley M.P.
        • Gulin J.P.
        • Felson D.T.
        Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis.
        JAMA. 2000; 283: 1469-1475
        • Gabay C.
        • Medinger-Sadowksi C.
        • Gascon D.
        • Kolo F.
        • Finckh A.
        Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis.
        Arthritis Rheum. 2011; 63: 3383-3391
        • Verbruggen G.
        • Goemaere S.
        • Veys E.M.
        Chondroitin sulfate: S/DMOAD (structure/disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA.
        Osteoarthritis Cartilage. 1998; 6: 37-38
        • Reginster J.Y.
        • Deroisy R.
        • Rovati L.C.
        • et al.
        Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial.
        Lancet. 2001; 357: 251-256